Authors
Xiaonan Liu, Yue Ren, Shu Li, Yuming Peng
Published in
Journal of neurosurgical anesthesiology. Oct 15, 2026. Epub Oct 15, 2026.
Abstract
The oncologic safety of intraoperative cell salvage (ICS) during meningioma surgery remains controversial due to concerns about hematogenous tumor dissemination. We investigated the association between ICS use and postoperative tumor recurrence in patients undergoing meningioma resection.
This study retrospectively included adult patients who underwent meningioma resection with intraoperative blood loss >1000 mL at Beijing Tiantan Hospital between August 2015 and November 2022. The primary outcome was postoperative tumor recurrence. Propensity scores were estimated using clinically relevant baseline variables, and inverse probability of treatment weighting with stabilized weights was applied to reduce confounding.
Among 988 patients, 89 (9.0%) developed recurrence during a mean follow-up of 60 months. Recurrence was less frequent in patients receiving ICS than in those without ICS (7.9% vs. 14.9%, P=0.004). After inverse probability of treatment weighting adjustment, baseline characteristics were well balanced between groups. In the weighted Cox model, ICS use was not associated with increased recurrence risk (HR=0.62, 95% CI: 0.39-0.99, P=0.043). Higher WHO grade was independently associated with increased recurrence risk, whereas gross total resection was associated with reduced risk. Sensitivity analyses yielded consistent results.
In patients undergoing meningioma surgery with substantial intraoperative blood loss, intraoperative cell salvage was not associated with an increased risk of tumor recurrence.
PMID:
42885656
Bibliographic data and abstract were imported from PubMed on 16 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0